The Green Brief



    Lead Story
    Trump Admin Claims Authority to Crack Down on Intoxicating Hemp
    The Trump administration has asserted new legal authority to dismantle the intoxicating hemp products market, a move that could reshape the delta-8 and hemp-derived cannabinoid sector that has operated in a regulatory gray zone since the 2018 Farm Bill. Separately, a congressional report is clarifying both the scope and the limitations of the administration's marijuana rescheduling action, offering the industry its clearest picture yet of what Schedule III status means operationally—including whether 280E tax relief will materialize as anticipated. Together, the two federal developments signal an increasingly active executive posture on cannabis regulation, creating simultaneous headwinds for hemp operators and cautious optimism for plant-touching MSOs watching the rescheduling process.
    Full analysis →

    

    Policy & Regulatory Watch
    
      Federal
      NPR reports the Trump administration has eased rules on certain marijuana categories as the rescheduling process advances, though a new congressional analysis warns that Schedule III status carries significant limitations for both consumers and industry operators.
    
    
      State
      North Carolina lawmakers are advancing a new bill that could alter the state's cannabis legality in 2026, while Pennsylvania legislators are debating the formation of a Cannabis Control Board as a potential pathway to adult-use legalization.
    
    
      Federal
      The Immigrant Legal Resource Center has issued new guidance reminding noncitizens that cannabis activity—even in legal states—continues to carry severe immigration consequences regardless of federal rescheduling status.
    

    

    Market Pulse
    
      
        MSOS
        $5.05
        -3.63%
      
      
        CURLF
        $3.89
        -1.07%
      
      
        TLRY
        $5.56
        -1.77%
      
      
        GTBIF
        $7.87
        -2.84%
      
      
        CRLBF
        $1.03
        -6.36%
      
      
        AYRWF
        $0.01
        -2.26%
      
    

    

    Quick Hits
    
      
      
        Curaleaf opened two new medical dispensaries in Jacksonville Beach and Fernandina Beach, Florida, bringing its statewide count to 73 and its national footprint to 165 locations.
        PR Newswire · 18h ago
      
    
    
      
      
        Cresco Labs released its Q1 2026 financial results, highlighting multiple growth initiatives even as shares of CRLBF fell more than 6% Friday to close at $1.03.
        Financial Post · 20h ago
      
    
    
      
      
        A new study published via The Conversation finds that higher-potency medicinal cannabis products are associated with a disturbing pattern of adverse effects including anxiety, psychosis, and paranoia.
        The Conversation Africa · 16h ago
      
    
    
      
      
        The global medical marijuana market is projected to surpass $130 billion as rapid legalization, rising clinical adoption, and growing institutional capital fuel accelerating worldwide demand.
        Associated Press · 14h ago
      
    

    

    From the Culture Desk
    
      
      
        The Machine Behind the Message: The Definitive Story of Smart Approaches to Marijuana and Kevin Sabet
        An investigation into the people, money, and organizational network behind America's most influential anti-cannabis organization.
        Read on cannanews.io →
        22 min read
      
    

    

    
      Seed & Stem — Today’s Context
      Cannabis is a photoperiod plant: it begins flowering when daily light drops below roughly 12 hours. Indoor cultivators manipulate this artificially, "flipping" lights from 18-hour vegetative cycles to 12-hour flowering schedules — giving them year-round harvests that outdoor farmers, bound by the seasons, can match only in count, not in unit economics.
The Green Brief — May 9, 2026
